Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab-Reference-Cited by-同舟云学术

Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab

Published:2018-06 Issue:6 Volume:28 Page:147-152
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Ingle James N.,Kalari Krishna R.,Wickerham Donald Lawrence,von Minckwitz Gunter,Fasching Peter A.,Furukawa Yoichi,Mushiroda Taisei,Goetz Matthew P.,Barman Poulami,Carlson Erin E.,Rastogi Priya,Costantino Joseph P.,Cairns Junmei,Paik Soonmyung,Bear Harry D.,Kubo Michiaki,Wang Liewei,Wolmark Norman,Weinshilboum Richard M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference13 articles.

1. Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015;Coates;Ann Oncol,2015

2. Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma;Weidner;N Engl J Med,1991

3. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer;Miller;N Engl J Med,2007

4. Bevacizumab added to neoadjuvant chemotherapy for breast cancer;Bear;N Engl J Med,2012

5. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial;Bear;Lancet Oncol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy;Genome Medicine;2024-01-12

2. A universal and sensitive gene mutation detection method based on CRISPR-Cas12a;Analytica Chimica Acta;2023-03

3. Genome‐wide association studies of survival in 1520 cancer patients treated with bevacizumab‐containing regimens;International Journal of Cancer;2021-10-05

4. Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine;Briefings in Bioinformatics;2020-12-01